People using weight loss injections, specifically GLP-1RA drugs, are being urged to take a good look at their diet. These ...

KANSAS CITY, MISSOURI, US — Already on the path toward healthier, nutrient-dense products, the increasing popularity of GLP-1 ...

San Francisco's Montara Therapeutics won a key $3.3 million grant from the Michael J. Fox Foundation for Parkinson's Research ...

Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...

Columnist Jen Cueva talks with her friend Lynda Pinto, who has PH, about Lynda's experience with GLP-1 agonist medications.

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.

Treating nicotine addiction with glucagon-like peptide 1 receptor agonists is associated with less weight gain compared with ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The recent decision by some US states to cover glucagon-like peptide-1 (GLP-1) agonists for obesity treatment marks a shift ...

The problem was resolved Thursday, when lawmakers sent a $240 million supplemental budget to Governor Maura Healey, which she ...